Inimmune is developing vaccines to treat food allergies. Read about the future prospects of treatments for food allergies here.
- Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
- Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm
- Montana Biotech Company Receives $2 M Small Business Innovation Research Grant to Advance Vaccine Technologies
- Development of COVID-19 Vaccine, Tests Advancing in Montana
- Science Behind the Silent Killer